NEW YORK (360Dx) – Diagnostic tests from the Centers for Disease Control and Prevention, Agilent Technologies, and Abbott Laboratories received 510(k) clearance from the US Food and Drug Administration last month.

The CDC was granted clearance for its Human Influenza Virus Real-Time RT-PCR Diagnostic Panel; Influenza A/B Typing Kit; Influenza A Subtyping Kit (ver 2); Influenza B Lineage Genotyping Kit; and Influenza A/H5 Subtyping Kit (ver 3).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.